Oncotarget
@Oncotarget
Followers
3K
Following
7K
Media
3K
Statuses
13K
Oncotarget is a peer-reviewed, open-access biomedical journal indexed in MEDLINE, PubMed, PMC, Scopus, and more.
Orchard Park, NY
Joined February 2016
🚴♂️The Open Access Team, sponsored by Impact Journals (Oncotarget's publisher), proudly participated in the 30th Ride for Roswell, contributing to a record-breaking $6+ million raised to help end #cancer @RoswellPark. #RFR25 #RideForRoswell #CancerResearch #OpenAccess
1
2
6
Currently more than 26,000 Oncotarget papers are searchable on #PubMed: . . #publishing #cancer #research #openaccess #peerreviewed #journalpublication.
pubmed.ncbi.nlm.nih.gov
oncotarget [ta] - Search Results - PubMed
0
0
0
Oncotarget is proud to be a #media partner for the 2nd European Cancer and Oncology Congress, taking place in Prague from November 3–4, 2025. 🧬 Learn more here:. #CancerResearch #Conference #Cancer #Oncology #OncologyCongress #Research
0
0
0
#OncotargetShort:.👀 Abstract #video about this #research paper #published on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." @ICR_London . #cancer #myeloma #oncology #oa #publishing
0
1
1
RT @OncoscienceJrnl: How to #contact Oncoscience: .. #research #publishing #journalpublication #openaccess #peerrev….
oncoscience.us
0
1
0
RT @OncoscienceJrnl: #PaperoftheDay: "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiati….
oncoscience.us
https://doi.org/10.18632/oncoscience.603 Richard L.J. Qiu, Chih-Wei Chang, Xiaofeng Yang
0
1
0
📈 #TrendingWithImpact:.This #research paper was recently #published in Volume 16, entitled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma.". #PressRelease ⬇️ . #cancer #myeloma #openaccess #publishing #press.
oncotarget.com
“Our findings suggest a role for NSD2 in maintaining MM cell identity, with potential implications for future therapeutic strategies based on targeting of NSD2.”
0
1
1
🖥️ To submit a paper online with Oncotarget, please visit: . #peerreviewed #journal #openaccess #openscience #publishing #author #research #cancer #oncology #publication.
0
0
1
#PaperoftheDay: "PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion". DOI ⬇️ . #cancer #research #oncology #oa #peerreview #publishing.
oncotarget.com
https://doi.org/10.18632/oncotarget.28759 Jassy Mary S. Lazarte, Kweku Ofosu-Asante, Syreeta L. Tilghman, Nazarius S. Lamango
0
0
0
✅ Read a #blog summary about this #research paper recently #published in Volume 16: "Assessment of cfDNA release dynamics during colorectal cancer surgery.". #Summary ⬇️. #cancer #colorectalcancer #surgery #trendingwithimpact #openaccess #cfDNA.
oncotarget.org
Imagine if a single blood test could tell clinicians in real time how successful a cancer surgery has been. A recent study published in Oncotarget, suggests that such an approach might soon be...
0
0
0
Oncotarget's Special Collection on Skin Cancer:. 🔗 . #skincancer #cancerresearch #cancer #collection #openaccess #research.
oncotarget.com
Open-access, peer-reviewed research on Skin Cancer from Oncotarget
0
0
0
Visit the Oncotarget #archive, containing papers #published since 2010: #cancer #oncology #research #peerreviewed #journal #openaccess #publishing.
oncotarget.com
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal that has been publishing research since 2010
0
0
0
#OncotargetShort:.👀 #video about this #editorial recently #published in Volume 16, titled "COMETgazing - interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE." @KingsCollegeLon . #cancer #breastcancer
1
0
0
📈 #TrendingWithImpact:.A new #editorial was recently #published in Volume 16, titled "COMETgazing - interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE.". #PressRelease ⬇️ . #cancer #breastcancer #oa.
oncotarget.com
"These suggest that not an insignificant proportion of invasive cancers may also be overdiagnosed as indolent cancers with a very long lead time or cancers that spontaneously regress.”
0
0
0
RT @OncoscienceJrnl: Explore the latest #research published by Oncoscience ⬇️ .. #openaccess #peerreviewed #publish….
oncoscience.us
0
1
0
RT @OncoscienceJrnl: #PaperoftheDay: "Primary hepatic angiosarcoma: Treatment options for a rare tumor". DOI ⬇️ . #….
oncoscience.us
https://doi.org/10.18632/oncoscience.602 Gregory L. Guzik, Ankit Mangla
0
1
0
At Oncotarget, #scientificintegrity is our priority. We use Argos by @ScitilityPBC to flag #research risks based on author records, retractions, & misconduct. From 2021-24, 0 high-risk papers were flagged. The results ⬇️ . #openaccess #publishing.
oncotarget.com
Scientific integrity is a crucial component of publishing reliable research. Learn about Oncotarget's diligent scientific integrity process.
0
0
0
#PaperoftheDay: "NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer". DOI ⬇️ . #cancer #research #oncology #openaccess #peerreview #journal #publishing.
oncotarget.com
https://doi.org/10.18632/oncotarget.28232 Travis P. Schrank, Andrew C. Prince, Tejas Sathe, Xiaowei Wang, Xinyi Liu, Damir T. Alzhanov, Barbara Burtness, Albert S. Baldwin, Wendell G. Yarbrough,...
0
0
0
📈 #TrendingWithImpact:.A new #research paper was #published on July 25, 2025, titled “Comprehensive genomic profiling of over 10,000 advanced solid tumors.” @ExactSciences . 🔗 #cancer #quote #oncology #tumor #oa #peerreview #journal #publishing
0
0
0
🎧 Listen to our #pressrelease about the #researchpaper, "Comprehensive genomic profiling of over 10,000 advanced solid tumors.". #cancer #podcast #audio #soundcloud #tumors #oncology #research #TrendingWithImpact #openaccess #publishing #press #journal.
0
0
0